TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33409684

Group type: EXPERIMENTAL
Intervention: Standard dose of meropenem (3 g daily) for 48 hours
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Adjusted dose of meropenem based on Cockcroft‐Gault equation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard and adjusted doses of meropenem
Number of subjects: 15
Study: 34733454

Group type: EXPERIMENTAL
Intervention: PACU experimental group
Number of subjects: 135

Group type: COMPARATOR
Intervention: PACU control group
Number of subjects: 135

Group type: COMPARATOR
Intervention: OR group
Number of subjects: 135
Study: 32984892

Group type: EXPERIMENTAL
Intervention: sACE2 protein level measured by Olink Proteomics® Multiplex CVD II96 × 96 panel
Number of subjects: 5087

Group type: EXPERIMENTAL
Intervention: sACE2 level
Number of subjects: 5087

Group type: EXPERIMENTAL
Intervention: sACE2 level adjusted for biomarkers
Number of subjects: 5087

Group type: EXPERIMENTAL
Intervention: GDF‐15 and NT‐proBNP levels
Number of subjects: 5087
Study: 33839803

Group type: EXPERIMENTAL
Intervention: Robotic-assisted technique
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 33073598

Group type: EXPERIMENTAL
Intervention: Offering one fixed BSS appointment
Number of subjects: 1908

Group type: EXPERIMENTAL
Intervention: Offering two fixed BSS appointments
Number of subjects: 1908

Group type: EXPERIMENTAL
Intervention: Offering four fixed BSS appointments
Number of subjects: 1908

Group type: EXPERIMENTAL
Intervention: Offering six fixed BSS appointments
Number of subjects: 1908
Study: 32114502

Group type: EXPERIMENTAL
Intervention: Acalabrutinib monotherapy (100 mg twice daily)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Acalabrutinib combined with pembrolizumab (200 mg on day 1 of each 3-week cycle)
Number of subjects: 77
Study: 33548529

Group type: EXPERIMENTAL
Intervention: Minimally invasive (MIS) endoscopic ICH evacuation
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (medical management)
Number of subjects: 21
Study: 32151708

Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 26

Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 26
Study: 35585521

Group type: EXPERIMENTAL
Intervention: Pēpi Splint
Number of subjects: 38
Study: 32385647

Group type: EXPERIMENTAL
Intervention: 500 ml sodium chloride and 20 mg furosemide
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 500 ml sodium chloride and 40 mg furosemide
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 500 ml sodium chloride
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: No preparation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no preparation)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (sodium chloride)
Number of subjects: 200
Study: 32648395

Group type: EXPERIMENTAL
Intervention: herb-separated moxibustion combined with budesonide nasal spray (rhinocort), 64 μg each spray, twice daily for 4 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: budesonide nasal spray (rhinocort), 64 μg each spray, twice daily for 4 weeks
Number of subjects: 70
Study: 35691371

Group type: EXPERIMENTAL
Intervention: 4-month relational agent coupled with AliveCor Kardia for heart rate and rhythm monitoring
Number of subjects: 264

Group type: COMPARATOR
Intervention: Pre-installed smartphone-based application for health-related information (WebMD)
Number of subjects: 264
Study: 33894856

Group type: COMPARATOR
Intervention: Traditional Sitting Position (TSP)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Hamstring Stretch Position (HSP)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Squatting Position (SP)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: All groups (TSP, HSP, SP)
Number of subjects: 360
Study: 32298853

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 1155
Study: 33983076

Group type: EXPERIMENTAL
Intervention: Pre-filled saline syringes
Number of subjects: 41

Group type: COMPARATOR
Intervention: Manual preparation of saline syringes
Number of subjects: 41
Study: 34232832

Group type: EXPERIMENTAL
Intervention: Proposed flexible proportional-odds models for estimating conditional event-probabilities
Number of subjects: 0
Study: 32473186

Group type: EXPERIMENTAL
Intervention: GAMotion (giant exercising board game)
Number of subjects: 21
Study: 36410828

Group type: EXPERIMENTAL
Intervention: Personalised postprandial glucose targeting diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 0
Study: 34146093

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Control (no BCG vaccination)
Number of subjects: 1272
Study: 33658142

Group type: EXPERIMENTAL
Intervention: Educational intervention using a website to create a short film about organ donation and transplantation (broadcast on YouTube)
Number of subjects: 863

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 863
Study: 32249355

Group type: EXPERIMENTAL
Intervention: BALANCE intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 38
Study: 35303929

Group type: EXPERIMENTAL
Intervention: General anesthesia with propofol
Number of subjects: 400

Group type: COMPARATOR
Intervention: General anesthesia with sevoflurane
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: General anesthesia with propofol and intravenous lidocaine
Number of subjects: 400

Group type: COMPARATOR
Intervention: General anesthesia with sevoflurane and intravenous lidocaine
Number of subjects: 400
Study: 33326172

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 131
Study: 32610568

Group type: EXPERIMENTAL
Intervention: EC‐150 (intermittent external compression with pressure of 150% AOP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CONT (control, without external compression)
Number of subjects: 10
Study: 35995689

Group type: EXPERIMENTAL
Intervention: Video-assisted operating room promotion program
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study: 33308131

Group type: EXPERIMENTAL
Intervention: Biological therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immunosuppressive therapy
Number of subjects: 0
Study: 32224233

Group type: EXPERIMENTAL
Intervention: Oral antidiabetic drugs (glyburide, metformin, or pioglitazone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ETA-receptor blockade
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetylcholine and sodium nitroprusside
Number of subjects: 0
Study: 33865836

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 108

Group type: COMPARATOR
Intervention: Neutral protamine Hagedorn
Number of subjects: 108
Study: 34397689

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir (ATV/r)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted darunavir (DRV/r)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Raltegravir (RAL)
Number of subjects: 75

Group type: COMPARATOR
Intervention: INSTI-based regimen (RAL)
Number of subjects: 75

Group type: COMPARATOR
Intervention: PI-based regimens (ATV/r and DRV/r)
Number of subjects: 75
Study: 32789883

Group type: EXPERIMENTAL
Intervention: DI*02(2558T) allele
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: DI*02(2534T) allele
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: DI*02(2358_2359insCAC) allele
Number of subjects: 1150

Group type: EXPERIMENTAL
Intervention: DI*02(2572T) allele
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Wild-type DI*02 constructs
Number of subjects: 1150
Study: 35045564

Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri ATCC PTA 4659
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 34714771

Group type: EXPERIMENTAL
Intervention: Three-component lifestyle intervention (LSI) with SMS support
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Three-component lifestyle intervention (LSI) without SMS support
Number of subjects: 183

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Combined LSI groups vs CAU
Number of subjects: 183
Study: 32464608

Group type: EXPERIMENTAL
Intervention: Compressed sensing convolutional neural network (CS-CNN) model for AF screening
Number of subjects: 0
Study: 35549331

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 157
Study: 32062040

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3
Number of subjects: 25871

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25871
Study: 32981134

Group type: EXPERIMENTAL
Intervention: Increased levels of apoB, LDL cholesterol, and triglycerides
Number of subjects: 514791

Group type: EXPERIMENTAL
Intervention: Decreased levels of apoA-I and HDL cholesterol
Number of subjects: 514791

Group type: EXPERIMENTAL
Intervention: apoB
Number of subjects: 514791

Group type: EXPERIMENTAL
Intervention: LDL cholesterol
Number of subjects: 514791

Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 514791

Group type: EXPERIMENTAL
Intervention: apoA-I
Number of subjects: 514791
Study: 35338314

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0
Study: 33844928

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 68
Study: 36336323

Group type: EXPERIMENTAL
Intervention: Cold air blower (CAB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard fan (FAN)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 20
Study: 33624798

Group type: EXPERIMENTAL
Intervention: VVZ-149 Injections (10-hour intravenous infusion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33247955

Group type: EXPERIMENTAL
Intervention: berotralstat 150 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: berotralstat 110 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study: 34383100

Group type: EXPERIMENTAL
Intervention: Teriparatide (20 μg/day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 32588153

Group type: EXPERIMENTAL
Intervention: Daikenchuto (DKT) 15 g per day during the perioperative period
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Daikenchuto (DKT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 35877930

Group type: EXPERIMENTAL
Intervention: Gradual cessation group (n=29)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Abrupt cessation group (n=41)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 32567870

Group type: EXPERIMENTAL
Intervention: anticlust software package
Number of subjects: 0
Study: 34710314

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 33933734

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zinc deficiency
Number of subjects: 0
Study: 33757140

Group type: EXPERIMENTAL
Intervention: Early Parent Participation Program (EPPP)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Conventional Care (CC)
Number of subjects: 147
Study: 33934476

Group type: EXPERIMENTAL
Intervention: Food supplement and topical solution containing nanosilicon
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35631185

Group type: EXPERIMENTAL
Intervention: Digital food label intervention (Nutri-Score displayed next to products)
Number of subjects: 135
Study: 33092404

Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg/day
Number of subjects: 112
Study: 32828845

Group type: EXPERIMENTAL
Intervention: PRF‐CS
Number of subjects: 10

Group type: COMPARATOR
Intervention: PRF‐X
Number of subjects: 10
Study: 35981135

Group type: EXPERIMENTAL
Intervention: BROAD light therapy (very brightly illuminated room for at least 6 hours per day for 4 weeks)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard 10,000 lux SAD light box (30 minutes in front of the light box for 4 weeks)
Number of subjects: 62
Study: 34151817

Group type: EXPERIMENTAL
Intervention: DBS-f stimulation ('on')
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham DBS-f ('off')
Number of subjects: 42
Study: 34304969

Group type: EXPERIMENTAL
Intervention: Usual care and exercise (3-weekly 40 min sessions of unsupervised, moderate-intensity home rowing program over 3 months)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 45
Study: 32147878

Group type: EXPERIMENTAL
Intervention: Anatomical occlusal reduction (Group O)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Anatomical occlusal reduction with round shoulder preparation (Group OS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No preparation of tooth (Control group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Anatomical occlusal reduction with a central groove (Group OG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Anatomical occlusal reduction with round shoulder preparation and central groove (Group OSG)
Number of subjects: 50
Study: 36414518

Group type: EXPERIMENTAL
Intervention: local neck treatment (NT) + JPS/oculomotor exercises (JPS/OC)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: local neck treatment (NT) + balance exercises
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: all treatments (NT + JPS/OC + balance exercises)
Number of subjects: 152

Group type: COMPARATOR
Intervention: local neck treatment (NT)
Number of subjects: 152
Study: 33533581

Group type: EXPERIMENTAL
Intervention: Reversing half-hitch alternating post (RHAP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Square knot
Number of subjects: 20
Study: 32552446

Group type: EXPERIMENTAL
Intervention: Couples Mindfulness-Based Intervention (C-MBI)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Individual Mindfulness-Based Intervention (I-MBI)
Number of subjects: 77
Study: 33798455

Group type: EXPERIMENTAL
Intervention: Pirfenidone (267 mg three times per day in week 1, 534 mg three times per day in week 2, and 801 mg three times per day thereafter)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 35314480

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 13

Group type: COMPARATOR
Intervention: Tolvaptan alone
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Combination treatment (Tolvaptan + Hydrochlorothiazide)
Number of subjects: 13
Study: 34246198

Group type: EXPERIMENTAL
Intervention: vNOTES
Number of subjects: 67

Group type: COMPARATOR
Intervention: Laparoscopy
Number of subjects: 67
Study: 32541171

Group type: EXPERIMENTAL
Intervention: Vitamin K1 ointment applied twice a day for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo ointment applied twice a day for 8 weeks
Number of subjects: 30
Study: 36082248

Group type: EXPERIMENTAL
Intervention: Maraviroc 150 or 600 mg/day
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 32513299

Group type: EXPERIMENTAL
Intervention: Anluohuaxian Pill
Number of subjects: 750

Group type: COMPARATOR
Intervention: Regular treatment (basic therapeutic drugs for COVID-19)
Number of subjects: 750
Study: 34479602

Group type: EXPERIMENTAL
Intervention: In-person education
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Virtual education
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control
Number of subjects: 88
Study: 34185066

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 75
Study: 34751506

Group type: EXPERIMENTAL
Intervention: Vitality Acupunch exercise program (3 times a week, 40 min each session for 6 months)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Routine daily activities (Control group)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Vitality Acupunch exercise program
Number of subjects: 114
Study: 32597619

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate supplementation (0.3 g/kg per day for 7 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Dextrosol (control group)
Number of subjects: 18
Study: 35701054

Group type: EXPERIMENTAL
Intervention: Structured care intervention in type 2 diabetes (part of the ERMIES trial)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Health Literacy Questionnaire (used in second round interviews)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Diet and exercise management
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Social support and relationship to health professionals
Number of subjects: 44
Study: 32704155

Group type: EXPERIMENTAL
Intervention: Action Observation (AO)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Motor Imagery (MI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo Observation (PO)
Number of subjects: 45
Study: 34369695

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment with filiform needles inserted perpendicularly, 3 mm in depth, with electric stimulation (2 Hz, 30 min, 3 times a week for 14 treatments)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo needling method (needle not inserted through skin) with electric stimulation (2 Hz, 30 min, 3 times a week for 14 treatments)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment
Number of subjects: 62
Study: 34519668

Group type: EXPERIMENTAL
Intervention: Mental health app use
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Perceived need to seek help
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Past use of professional mental health services
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Social influence
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Privacy concerns
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Stigma, age, and gender
Number of subjects: 500
Study: 34015765

Group type: EXPERIMENTAL
Intervention: Bone mineral density (BMD) at heel
Number of subjects: 1523

Group type: EXPERIMENTAL
Intervention: Other BMD sites (forearm, femoral neck, lumbar spine, total body)
Number of subjects: 1523

Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA)
Number of subjects: 1523
Study: 35616251

Group type: EXPERIMENTAL
Intervention: SI‐TEAS Group
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Acupressure Group
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sham Acupressure Group
Number of subjects: 300
Study: 33632286

Group type: EXPERIMENTAL
Intervention: Auricular point acupressure group
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Sham auricular point acupressure group
Number of subjects: 360

Group type: COMPARATOR
Intervention: Blank control group
Number of subjects: 360
Study: 32699168

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg once per day
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg once per day with CPAP
Number of subjects: 132

Group type: COMPARATOR
Intervention: CPAP alone (conventional care)
Number of subjects: 132

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 132
Study: 35688793

Group type: EXPERIMENTAL
Intervention: Low resistance kinetics
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: High resistance kinetics
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Sensitive kinetics
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Refractory kinetics
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Complete response (CR) with refractory kinetics
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Rapid responders
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: Late responders
Number of subjects: 373
Study: 32750916

Group type: EXPERIMENTAL
Intervention: Camera-based HR monitoring technique using iPPG signals extracted from video recordings.
Number of subjects: 9
Study: 32396206

Group type: EXPERIMENTAL
Intervention: 10-week nurse-led intervention for adolescents with PIU
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-list control group (received intervention after posttest)
Number of subjects: 100
Study: 35138027

Group type: EXPERIMENTAL
Intervention: Sonic application of iBond Self‐Etch adhesive
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual application of iBond Self‐Etch adhesive
Number of subjects: 40
Study: 33398936

Group type: EXPERIMENTAL
Intervention: PEERS® intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 0
Study: 34161776

Group type: EXPERIMENTAL
Intervention: REGEN-COV (two-antibody combination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single monoclonal antibody treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dual or triple antibody combinations (in vitro studies)
Number of subjects: 0
Study: 32155576

Group type: EXPERIMENTAL
Intervention: Intensive education group (IEG)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Regular education group (REG)
Number of subjects: 92
Study: 33417507

Group type: EXPERIMENTAL
Intervention: Hand-held (HH) Nomad Pro 2 X-ray device
Number of subjects: 205

Group type: COMPARATOR
Intervention: Wall-mounted (WM) KaVo Focus X-ray device
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Both HH and WM devices
Number of subjects: 205
Study: 32476539

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 6540

Group type: COMPARATOR
Intervention: No ICD
Number of subjects: 6540
Study: 36223599

Group type: EXPERIMENTAL
Intervention: Transvaginal hydrolaparoscopy (THL)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Hysterosalpingography (HSG)
Number of subjects: 300
Study: 34034702

Group type: EXPERIMENTAL
Intervention: DNA methylation of seven CpGs (cg10399824, cg05275153, cg24406668, cg14719951, cg25117092, cg11348188, cg11671115)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: DNA methylation of five CpGs (cg10399824, cg24406668, cg14719951, cg25117092)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Three methylation correlated blocks (MCBs) involving cg11671115, cg14719951, and cg24406668
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: Two risk score models based on key CpG loci
Number of subjects: 381
Study: 35149907

Group type: EXPERIMENTAL
Intervention: Lemna minor
Number of subjects: 24

Group type: COMPARATOR
Intervention: Spinach
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lemna minor and Spinach
Number of subjects: 24